Wednesday, 9th January , 2019, 10:47 pm,BDST
Print Friendly, PDF & Email

Breast cancer new potential drug identified



Lastnewsbd, 9th January, Dhaka: First-in-class drugs are those that work by a unique mechanism – in this case a molecule that targets a protein on the oestrogen receptor of tumour cells. The potential drug offers hope for patients whose breast cancer has become resistant to traditional therapies. “This is a fundamentally different, new class of agents for oestrogen-receptor-positive breast cancer,” said Ganesh Raj, professor at the University of Texas Southwestern (UT Southwestern) Simmons Cancer Center. “Its unique mechanism of action overcomes the limitations of current therapies,” Raj said. All breast cancers are tested to determine if they require oestrogen to grow and about 80 per cent are found to be oestrogen-sensitive, researchers said. These cancers can often be effectively treated with hormone therapy, such as tamoxifen, but as many as a third of these cancers eventually become resistant, they said. The new compound is a potential highly effective, next-line treatment for these patients, said Raj.

Scientists, including an Indian-American researcher, have identified a molecule that can help treat breast cancer, giving hope to patients who have become resistant to traditional therapies. The first-in-class molecule shuts down oestrogen-sensitive breast cancer in a new way, researchers said. Traditional hormonal drugs, such as tamoxifen, work by attaching to a molecule called the oestrogen receptor in cancer cells, preventing oestrogen from binding to the receptor, a necessary step for cancer cells to multiply. However, the oestrogen receptor can mutate and change its shape over time so that the treatment drug no longer fits neatly with the receptor. When this happens, the cancer cells start multiplying again. “There has been intense interest in developing drugs that block the ability of the oestrogen receptor – the prime target in most breast cancers – from interacting with the co-regulator proteins that cause a tumour’s growth,” said David Mangelsdorf, professor at UT Southwestern. “Blocking such “protein-protein interactions” has been a dream of cancer researchers for decades. The drug works by blocking other molecules – proteins called co-factors – that also must attach to the oestrogen receptor for cancer cells to multiply. The new molecule, dubbed ERX-11, mimics a peptide, or protein building block.

Source: PTI

 

Print Friendly, PDF & Email
Print Friendly, PDF & Email

Comments are closed

bsti
exim bank
পেপার কর্ণার
Last News BD
islame bank
অনলাইন জরিপ
আজকের প্রশ্ন >

Do you think BNP will participate coming election?

View Results

Loading ... Loading ...
আর্কাইভ
January 2019
S S M T W T F
« Dec   Feb »
 1234
567891011
12131415161718
19202122232425
262728293031  
মতামত
সাক্ষাৎকার
জেলার খবর
Rangpur

    রংপুরের খবর

  • Structures Rongpur power plant have been tilted
  • Northern district is not militant free: IGP
  • "We are the opposition party": Ershad
  • Another Bangladeshi killed by BSF in Kurigram
  • Police arrested 58 people from several upazilas
  • AL leader murdered in Natore
  • 123km human chain against militancy
  • Priest murder accused held in Sholakia: Police
  • 3 of a family electrocuted in Lalmonirhat
  • Truck, Covered Van collision kills 2 at Rupnagar

Do you think BNP will participate coming election?

  • yes (81%, 13 Votes)
  • no (19%, 3 Votes)
  • no comment (0%, 0 Votes)

Total Voters: 16

Start Date: December 17, 2017 @ 5:58 pm
End Date: No Expiry

Will you agree with the statement of BNP general secretary Mirza Fakhrul Islam Alamgir that Government try to give big budget to cut pockets of the hostage people?

  • yes (80%, 8 Votes)
  • no (20%, 2 Votes)
  • no comment (0%, 0 Votes)

Total Voters: 10

Start Date: May 31, 2017 @ 8:43 pm
End Date: No Expiry

Do you think dialogue with president will be beneficial for political party's?

  • yes (63%, 5 Votes)
  • no (25%, 2 Votes)
  • no comment (12%, 1 Votes)

Total Voters: 8

Start Date: December 17, 2016 @ 2:00 am
End Date: No Expiry

How Is My Site?

  • Good (0%, 0 Votes)
  • Excellent (0%, 0 Votes)
  • Bad (0%, 0 Votes)
  • Can Be Improved (0%, 0 Votes)
  • No Comments (100%, 0 Votes)

Total Voters: 0

Start Date: December 17, 2016 @ 1:55 am
End Date: No Expiry